Taking Nanotechnology to Market: One Company's Strategy

Jun 26, 2006, 01:00 ET from Woodrow Wilson International Center for Scholars

    WASHINGTON, June 26 /PRNewswire/ -- Many people see nanotechnology as a
 futurist dream. Tomorrow's nano world promises pollution-free energy,
 potent cancer and Alzheimer's treatments, and faster, smaller, cheaper
     Few appreciate that nanotechnology is quickly moving out of
 laboratories and into factories, stores, and homes. Lux Research reports
 that more than $32 billion in products incorporating nanotechnology sold
 last year. These include about 300 nanotechnology consumer products, and an
 estimated 600 nanotechnology raw materials, intermediate components, and
 industrial equipment items used by manufacturers.
     What are the challenges of moving nanotechnology from laboratory to
 store shelves? How do you use nanotechnology to add value to products, and
 to shift competitive dynamics? Do you brand or not brand nanotechnology
 products, and how do you address consumer perceptions? What does
 responsible development of nanotechnology mean to a company?
     A program to address these and other questions will be held on
 Thursday, June 29th at 12:30 p.m. in the 6th floor board room of the
 Woodrow Wilson International Center for Scholars.
     The featured guest is Dr. Barry Park, chief operating officer of
 Oxonica. Oxonica is one of Europe's leading nanomaterials firms taking
 nano-enabled products from laboratory to market.
     The company was spun out of Oxford University in Great Britain in 1999.
 Its commercialized products include Envirox Fuel Borne Catalyst (used in
 diesel engines to reduce fuel consumption and particulate emissions) and
 Optisol UV Absorber (a photostable UV absorber that provides enhanced and
 longer lasting protection against UVA in suncare and anti-aging products).
 In 2005, Boots Group plc -- Britain's foremost pharmacy chain --
 incorporated Optisol in their new Soltan Facial Sun Defense Cream, now sold
 widely in stores throughout the United Kingdom.
     Dr. Park formerly worked for Raychem Ltd. He is co-author of 20
 scientific papers and is an inventor whose work has led to over 120 patents
 granted worldwide.
     This program is part of the Wilson Center's Project on Emerging
 Nanotechnologies' "Perspectives" series aimed at stimulating an informed
 dialogue on the development, commercialization, and oversight of
             ***Webcast LIVE at http://www.wilsoncenter.org/nano***
     What:  Taking Nanotechnology to Market: One Company's Strategy
     Who:   Barry Park, Ph.D., Chief Operating Officer, Oxonica
            Andrew Maynard, Ph.D., Chief Scientist, Project on Emerging
     When:  Thursday, June 29, 2006, 12:30 - 1:30 p.m.  (Lunch available
            starting at 12 noon.)
     Where: Woodrow Wilson International Center for Scholars, 6th Floor Board
            Room.  Ronald Reagan Building and International Trade Center, 1300
            Pennsylvania Avenue, NW.
     The Project on Emerging Nanotechnologies was launched in 2005 by the
 Woodrow Wilson Center and The Pew Charitable Trusts. It is dedicated to
 helping businesses, governments, and the public anticipate and manage the
 possible health and environmental implications of nanotechnology.
     Media planning to cover the event should contact Sharon McCarter at
 (202) 691-4016 or at sharon.mccarter@wilsoncenter.org.

SOURCE Woodrow Wilson International Center for Scholars